Literature DB >> 22066605

Self-assembling small molecules form nanofibrils that bind procaspase-3 to promote activation.

Julie A Zorn1, Holger Wille, Dennis W Wolan, James A Wells.   

Abstract

Modulating enzyme function with small-molecule activators, as opposed to inhibitors, offers new opportunities for drug discovery and allosteric regulation. We previously identified a compound, called 1541, from a high-throughput screen (HTS) that stimulates activation of a proenzyme, procaspase-3, to generate mature caspase-3. Here we further investigate the mechanism of activation and report the surprising finding that 1541 self-assembles into nanofibrils exceeding 1 μm in length. These particles are an unanticipated outcome from an HTS that have properties distinct from standard globular protein aggregators. Moreover, 1541 nanofibrils function as a unique biocatalytic material that activates procaspase-3 via induced proximity. These studies demonstrate a novel approach for proenzyme activation through binding to fibrils, which may mimic how procaspases are naturally processed on protein scaffolds.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22066605      PMCID: PMC3253528          DOI: 10.1021/ja208350u

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  27 in total

1.  A high-throughput screen for aggregation-based inhibition in a large compound library.

Authors:  Brian Y Feng; Anton Simeonov; Ajit Jadhav; Kerim Babaoglu; James Inglese; Brian K Shoichet; Christopher P Austin
Journal:  J Med Chem       Date:  2007-04-21       Impact factor: 7.446

2.  Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors.

Authors:  Kristin E D Coan; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2008-06-28       Impact factor: 15.419

3.  Turning enzymes ON with small molecules.

Authors:  Julie A Zorn; James A Wells
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

Review 4.  Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches.

Authors:  C L Wellington; M R Hayden
Journal:  Clin Genet       Date:  2000-01       Impact factor: 4.438

Review 5.  Zymogens of proteolytic enzymes.

Authors:  B Kassell; J Kay
Journal:  Science       Date:  1973-06-08       Impact factor: 47.728

6.  Inhibition of kinesin motor proteins by adociasulfate-2.

Authors:  Khalilah G Reddie; Donald R Roberts; Timothy M Dore
Journal:  J Med Chem       Date:  2006-08-10       Impact factor: 7.446

7.  Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein.

Authors:  Y Shibayama; K Joseph; Y Nakazawa; B Ghebreihiwet; E I Peerschke; A P Kaplan
Journal:  Clin Immunol       Date:  1999-01       Impact factor: 3.969

8.  In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues.

Authors:  I B Kingston; M J Castro; S Anderson
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

9.  Intermediate filaments control the intracellular distribution of caspases during apoptosis.

Authors:  David Dinsdale; Justine C Lee; Grant Dewson; Gerald M Cohen; Marcus E Peter
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

10.  Functional amyloid formation within mammalian tissue.

Authors:  Douglas M Fowler; Atanas V Koulov; Christelle Alory-Jost; Michael S Marks; William E Balch; Jeffery W Kelly
Journal:  PLoS Biol       Date:  2006-01       Impact factor: 8.029

View more
  32 in total

Review 1.  Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials.

Authors:  Xuewen Du; Jie Zhou; Junfeng Shi; Bing Xu
Journal:  Chem Rev       Date:  2015-12-08       Impact factor: 60.622

2.  Prion-like nanofibrils of small molecules (PriSM) selectively inhibit cancer cells by impeding cytoskeleton dynamics.

Authors:  Yi Kuang; Marcus J C Long; Jie Zhou; Junfeng Shi; Yuan Gao; Chen Xu; Lizbeth Hedstrom; Bing Xu
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

3.  Post-HTS case report and structural alert: Promiscuous 4-aroyl-1,5-disubstituted-3-hydroxy-2H-pyrrol-2-one actives verified by ALARM NMR.

Authors:  Jayme L Dahlin; J Willem M Nissink; Subhashree Francis; Jessica M Strasser; Kristen John; Zhiguo Zhang; Michael A Walters
Journal:  Bioorg Med Chem Lett       Date:  2015-08-10       Impact factor: 2.823

4.  Structural snapshots reveal distinct mechanisms of procaspase-3 and -7 activation.

Authors:  Nathan D Thomsen; James T Koerber; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

5.  Enzyme-instructed self-assembly of the stereoisomers of pentapeptides to form biocompatible supramolecular hydrogels.

Authors:  Adrianna N Shy; Jie Li; Junfeng Shi; Ning Zhou; Bing Xu
Journal:  J Drug Target       Date:  2020-07-27       Impact factor: 5.121

6.  Nanoscale Assemblies of Small Molecules Control the Fate of Cells.

Authors:  Junfeng Shi; Bing Xu
Journal:  Nano Today       Date:  2015-10-20       Impact factor: 20.722

7.  Mixing biomimetic heterodimers of nucleopeptides to generate biocompatible and biostable supramolecular hydrogels.

Authors:  Dan Yuan; Xuewen Du; Junfeng Shi; Ning Zhou; Jie Zhou; Bing Xu
Journal:  Angew Chem Int Ed Engl       Date:  2015-03-17       Impact factor: 15.336

8.  Fibrils colocalize caspase-3 with procaspase-3 to foster maturation.

Authors:  Julie A Zorn; Dennis W Wolan; Nicholas J Agard; James A Wells
Journal:  J Biol Chem       Date:  2012-08-07       Impact factor: 5.157

Review 9.  Innovation in academic chemical screening: filling the gaps in chemical biology.

Authors:  Samuel A Hasson; James Inglese
Journal:  Curr Opin Chem Biol       Date:  2013-05-14       Impact factor: 8.822

10.  Disruption of the dynamics of microtubules and selective inhibition of glioblastoma cells by nanofibers of small hydrophobic molecules.

Authors:  Yi Kuang; Bing Xu
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-17       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.